CHM.CN Waverunner Capital CNQ C$0.05 09 Feb 2026: Market-hours high-volume mover

CHM.CN stock moved to C$0.05 on 09 Feb 2026 during market hours after a one-day spike from C$0.005, a change of 900.00% that reflects extreme short-term re-rating. The rapid jump trades against low liquidity: reported average volume is 28,908 shares while live volume prints are thin or not reported. Waverunner Capital Inc. (CHM.CN) trades on the CNQ in Canada and remains a small-cap, venture-focused firm with a market cap near C$37,211,650.00. For high-volume mover strategies, this trade signals both opportunity and elevated execution risk as investors assess fundamentals and catalysts.

Market move and intraday flow for CHM.CN stock

The main fact is the intraday price change: CHM.CN stock rose from C$0.005 to C$0.05, a C$0.04500 move or 900.00% increase, on 09 Feb 2026 during market hours. That jump is consistent with low-float, low-liquidity stocks where a small order can move price sharply. Average daily volume sits at 28,908 while sector average for Healthcare is 114,605, so trading costs and slippage are likely high for larger orders.

Fundamentals and valuation context for CHM.CN stock

Waverunner Capital Inc. reports EPS -C$0.01 and a negative P/E of -5.00, reflecting losses and limited operating scale. Book value per share is negative at -0.10928 and cash per share is 0.01124, indicating constrained liquidity on the balance sheet. The company changed its name from Chemistree Technology in June 2024 and operates as a venture investor across early-stage and renewables, keeping revenue generation irregular and valuation metrics unreliable for standard comparables.

Technicals, liquidity and trading risk for CHM.CN stock

Price averages show a 50-day average C$0.04 and a 200-day average C$0.05, signaling the current price sits near multi-month averages. Shares outstanding are 744,233,000, but actual tradable float appears small relative to that number. With no reliable daily volume prints and large gaps between previous close and current price, stop placement and execution strategy matter: limit orders and position sizing should reflect potential 10% to 50% intraday swings.

Meyka AI grade, sector comparison and CHM.CN stock outlook

Meyka AI rates CHM.CN with a score out of 100: 64.97 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 comparison, Healthcare sector metrics, financial growth, key ratios, forecasts, analyst consensus and fundamentals. Compared with the Healthcare sector average P/E of 14.02, CHM.CN’s negative P/E underscores speculative profile. Investors should treat the grade as a data point only; it does not replace due diligence.

Price targets, forecasts and Meyka AI model for CHM.CN stock

Meyka AI’s forecast model projects a short-term scenario target of C$0.07 and a 12-month base-case target of C$0.12 versus the current C$0.05. That 12-month projection implies an upside of 140.00% from the current price. The model also flags a downside stress scenario to C$0.02 if liquidity dries up and no new catalysts emerge. Forecasts are model-based projections and not guarantees.

Catalysts, risks and trading strategy for CHM.CN stock

Potential catalysts include new PIPEs, disclosed investments in renewable projects or a corporate update from management. Key risks are thin liquidity, negative earnings, negative book value and the possibility of reversal after a sharp pump. For traders, we recommend small, measured positions, tight execution using limit orders, and clear exit rules. For investors, demand clearer revenue traction or a repeatable capital deployment strategy before increasing exposure.

Final Thoughts

CHM.CN stock moved sharply to C$0.05 on 09 Feb 2026 in market hours, driven by low liquidity and concentrated buying rather than clear fundamental news. Waverunner Capital Inc. remains a speculative, small-cap venture vehicle with EPS -C$0.01, negative book value and a market cap near C$37,211,650.00. Meyka AI’s forecast model projects a short-term scenario of C$0.07 and a 12-month base-case price target of C$0.12, an implied upside of 140.00% from today’s price, while noting a downside stress case to C$0.02. Meyka AI grades CHM.CN 64.97 (B, HOLD) based on sector, growth and key metrics. Given the Healthcare sector’s average liquidity and valuation norms, CHM.CN’s move should interest high-volume mover strategies but only with disciplined sizing and execution. Always use limit orders and confirm any corporate news or filings before trading; these forecasts are model-based and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.